Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-048025

Options or other derivatives

  • CFO and Treasurer acquired 11,286 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Krognes Steve E. CFO and Treasurer 2018-08-20 Grant or award · Restricted Stock Units +11,286 11,286 D
Loading xslF345X03/doc4.xml…